国際評価

国際学会発表(年代順)

2018年

欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark)
  1. Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Kimura T, Kudo K, Kumazawa I, Fujii Y. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 2018/3/16

  2. Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y.Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 2018/3/17

  3. Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Favorable locoregional control in patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy with lymph node dissection. 2018/3/18

  4. Fukushima H, Kobayashi M, Kwano K, Morimoto S. SOFA and quick SOFA are more clinically useful scoring systems than SIRS in predicting mortality of patients with acute pyelonephritis associated with upper urinary tract calculi. 2018/3/18

  5. Fukushima H, Kobayashi M, Kwano K, Morimoto S. Lower performance status is a risk factor for sepsis of patients with acute pyelonephritis associated with upper urinary tract calculi in the Sepsis-3 era. 2018/3/18

  6. Yajima S, Yoshida S, Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. 2018/3/19

  7. Soma T, Yoshida S, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. The usefulness of diffusion-weighted MRI in the differential diagnosis of urachal disorders. 2018/3/19

  8. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. 2018/3/19

  9. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades. 2018/3/19

  10. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy. 2018/3/19

  11. Yoshida S, Takahara T, Ishii C, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. METastasis reporting and data system for prostate cancer score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. 2018/3/19

  12. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. 2018/3/19

  13. Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction. 2018/3/19

  14. Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system. 2018/3/19

  15. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. 2018/3/19

国際前立腺と腎臓癌の部分治療と画像会議(The 10th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer, Noordwijk, The Netherlands)
  1. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Predictive significance of MRI-targeted biopsy for pathological and oncological outcomes after radical prostatectomy. 2018/2/12

  2. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Prognostic impact of prostate imaging reporting and data system scores on oncological outcome. 2018/2/12

2017年

米国泌尿器科学会(The 112th annual meeting of the American Urological Association, Boston, USA)
  1. Ishioka J, Matsuoka Y, Itoh M, Inoue M, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Fujii Y, Tanaka H, Kimura T. Computer-aided diagnosis of prostate cancer using a deep neural networks algorithm in pre-biopsy multiparametric magnetic resonance imaging. 2017/5/12

  2. Yokoyama M, Koga F, Otsuka Y, Tsukamoto T, Okuno T, Nagahama K, Kageyama Y, Noro A, Tsujii T. Impact of chronic kidney disease and hypertension on decline in remaining kidney function after radical nephrectomy. 2017/5/15

  3. Ito M, Inoue M, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Noboru Numao, Matsuoka Y, Saito K, Kihara K, Fujii Y. Short-term androgen deprivation therapy increases brain-type natriuretic peptide levels in patients with prostate cancer: Possible adverse impact on cardiac function. 2017/5/14

  4. Inoue M, Yasuhisa Fijii, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K. Incidence and risk factors of postoperative hypertension after partial nephrectomy for renal tumors. 2017/5/14

  5. Nakayama T, Saito K, Waseda Y, Tanaka H, Inoue M, Ito M, Kawamura N, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. Immunosuppressive tumor microenvironment in patients with clear cell renal cell carcinoma. 2017/5/13

  6. Nakayama T, Kijima T, Yoshida S, Koga F, Kihara K, Fujii Y. Zoledronic acid sensitizes castration-resistant prostate cancer cells to radiotherapy and chemotherapy by downregulating STAT1. 2017/5/15

  7. Yasuda Y, Saito K, Kawamura N, Uehara S, Yuasa T, Yokoyama M, Ishioka J, Matsuoka Y, Yamamoto S, Takahashi S, Okuno T. Protein predicts survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. 2017/5/12

  8. Waseda Y, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. New predictive scoring model for recurrence incorporating bladder neck involvement in patients with non-muscle-invasive bladder cancer. 2017/5/12

  9. Waseda Y, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. Predictive ability of renal cortex enhancement in dynamic CT for residual renal function after nephroureterectomy: Comparative study with renography. 2017/5/15

  10. Fukushima H, Nakanishi Y, Kataoka M, Tobisu K, Koga F. Post-therapeutic recovery of skeletal muscle mass predicts favorable prognosis in advanced urothelial carcinoma patients receiving 1st-line platinum-based chemotherapy. 2017/5/12

  11. Fukushima H, Nakanishi Y, Kataoka M, Tobisu K, Koga F. Prognostic significance of serum γ-glutamyltransferase in advanced urothelial carcinoma patients. 2017/5/13

欧州泌尿器科学会(The 32th European Association of Urology annual congress, London, UK)
  1. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Fujii Y. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 2017/3/27

  2. Kawamura N, Yokoyama M, Nakayama T, Tanaka H, Inoue M, Ito M, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Acute kidney injury after clampless partial nephrectomy: Incidence, predictors, and its low impact on intermediate-term renal function. 2017/3/27

  3. Izumi K, Saito K, Nakayama T, Fukuda S, Fukushima H, Uehara S, Koga F, Yonese J, Kageyama Y, Kihara K, Fujii Y.. Contact with renal sinus is a significant risk factor for metastasis in pT1 clear cell renal cell carcinoma. 2017/3/26

  4. Komai Y, Gotohda N, Sakai Y, Ito M. Preliminary kidney parenchymal ligation to achieve trifecta in zero-ischemia laparoscopic partial nephrectomy. 2017/3/25

  5. Nakamura Y, Tanaka H, Fujii Y, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. 2017/3/27

2016年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Fujii Y et al. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  2. Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  3. Matsuoka Y et al. Applicability analysis of focal therapy to intermediate- and high-risk prostate cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  4. Matsuoka Y et al. Impact of prebiopsy magnetic resonance imaging (MRI) on preoperative risk stratification for biochemical recurrence after radical prostatectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  5. Matsuoka Y et al. Impact of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) on the assessment of extracapsular extension in prostate cancer: A multireader study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9

  6. Ishioka J et al. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  7. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  8. Ishioka J et al. Yokoyama M., Kawamura N., Fujii Y., Inoue M., Ishioka J., Numao N., Matsuoka Y., Saito K., Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Longitudinal renal function recovery after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  9. Yoshida S et al. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  10. Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  11. Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  12. Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  13. Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9

  14. Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9

  15. Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  16. Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  17. Nakamura Y et al. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  18. Nakamura Y et al. High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  19. Fujiwara M et al. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  20. Fukushima H, Nakanishi Y, Kataoka M, Tobisu K, Koga F. Prognostic significance of postoperative skeletal muscle mass recovery in metastatic renal cell carcinoma patients who underwent cytoreductive nephrectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  21. Nakanishi Y, Fukushima H, Yokoyama M, Kataoka M, Tobisu K, Koga F. Can systematic biopsy be safely omitted in the era of MRI/TRUS-fusion targeted prostate biopsy? The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  2. Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  3. Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  4. Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  5. Yokoyama M, Kawamura N, Fujii Y, Inoue M, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K. Longitudinal changes in renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter study using a linear mixed model analysis. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  6. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  7. Yoshida S et al. Potential utility of standardized apparent diffusion coefficient value as a biomarker predicting clinical aggressiveness of bladder cancer with various MRI protocols at various institutions. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  8. Inoue M et al. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  9. Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  10. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  11. Waseda Y. et al. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  12. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  13. Fujiwara M et al. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  14. Yasuda Y, Saito K, Kawamura N, Yuasa T, Yokoyama M, Matsuoka Y, Ishioka J, Numao N, Okuno T, Yamamoto S, Takahashi S, Yonese J, Fujii Y, Kihara K. Prognostic significance of early CRP response for metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

国際磁気共鳴医学会(The 24th Annual meeting of International Society for Magnetic Resonance in Medicine, Singapore)
  1. Waseda Y, Yoshida S, Takahara T, Tanaka H, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, and Kihara K . Utility of computed diffusion-weighted imaging for predicting aggressiveness of prostate cancer. 2016/5/9

  2. Yoshida S, Koga F, Tanaka H, Fukushima H, Nakanishi Y, Yokoyama M, Ishioka J, Saito K, Fujii Y, Kihara K. Apparent diffusion coefficient ratio as a potential inter-institutional marker for histological grade of bladder cancer. 2016/5/12

2015年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K.. Recovery in renal function after radical nephrectomy and its negative predictive factors: a multicenter longitudinal study, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/18

  2. Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K.. Optimal MRI-targeted biopsy sampling number, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/17

  3. Fukushima H., Koga F., Nakanishi Y., Tobisu K.. Sarcopenia as a prognostic biomarker of metastatic renal cell carcinoma: Its effect on survival benefit from cytoreductive nephrectomy, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/15

  4. Fukushima H., Koga F., Nakanishi Y., Tobisu K.. Intensive local therapy to bone lesions may improve survival in renal cell carcinoma patients with bone metastasis, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/18

  5. Fujii, Y., Moriyama S., Yokoyama M., Yonese J., Noro A., Arisawa C., Morimoto S., Okuno T., Kitahara S., Koga F., Sakai Y., Suzuki M., Nagahama K., Izutani T., Saito K., Kihara K.. TMDU NMIBC group. Impact of bladder neck involvement on progression in patients with primary non-muscle-invasive bladder cancer: A multicenter validation study , The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/16

  6. Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S.m Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K.. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/18

  7. Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K.. Preoperative selection algorithm for eligible neoadjuvant chemotherapy patients in upper tract urothelial carcinomas, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/15

  8. Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features,, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/15

  9. Tatokoro M., Nakanishi Y., Komai Y., Matsuoka Y., Ishioka J., Numao N., Yoshimoto K., Saito K., Fujii Y., Ogawa Y., Kihara K.. Impact of impaired glucose tolerance on the development of hypoglycemia following removal of pheochromocytoma, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/15

  10. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K.. Development of new three-dimensional image system for transurethral surgery, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/16

  11. Yoshida S., Fukuda S., Kanda T., Fukui N., Saito K., Fujii Y., Kageyama Y, Kihara K.. Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/16

  12. Yoshida S., Tanabe K., Koga F., Inoue M., Kobayashi S., Ishioka J., Tamura T., Sugawara E., Saito K., Akashi T., Fujii Y., Kihara K.. Favorable survival outcomes after a chemoradiation-based multimodal approach against muscle-invasive bladder cancer with high Ki-67 expression, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/18

  13. Waseda Y., Ishikawa Y., Kawano K., Kihara K., Morimoto S.. Simple prediction of postoperative renal function with dynamic CT before nephroureterectomy: the ratio of renal cortex enhancement on diseased to contralateral kidney, The 111th annual meeting of the American Urological Association, New Orleans, USA, 2015/5/15

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Inoue M, Fujii Y, Yokoyama M, Ito M, Tatokoro M, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Saito K, Kihara K. Progression of hypertension after partial nephrectomy in Japanese patients with renal tumors. The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/21

  2. Ishioka J, Yokoyama M, Waseda Y,Kawamura N, Itoh M, Tatokoro M, Yoshida S, Matsuoka Y,Numao N, Saito K, Arisawa C, Morimoto S, Kageyama Y,Fujii Y, Kihara K. Preoperative prediction of postoperative renal function for upper tract urothelial carcinoma patients: Concerning issues of perioperative renal impairment and the use of cisplatin-based chemotherapy, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/23

  3. Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Longitudinal change and risk factors of severe deterioration in renal function after radical nephrectomy, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/23

  4. Komai Y., Matsubara N., Sakai Y., Saito N. Time-Lapse movie significantly improves patient comprehension and reduces time of informed consent explanation—initial experience in urologic surgery, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/22

  5. Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/22

  6. Tatokoro M., Nakanishi Y., Komai Y., Matsuoka Y., Ishioka J., Numao N., Yoshimoto K., Saito K., Fujii Y., Ogawa Y., Kihara K.. Impaired glucose tolerance predicts the development of hypoglycemia after removal of pheochromocytoma, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/22

  7. Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K.. Preoperative prediction algorithm for the selection of candidates for neoadjuvant chemotherapy in upper tract urothelial carcinomas, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/22

  8. Nakamura Y. , Numao N. , Yoshida S. , Komai Y. , Ito M. , Tatokoro M. , Yokoyama M. , Ishioka J. , Matsuoka Y. , Saito K. , Fujii Y. , Kihara K.  Transrectal 12-core prostate biopsy and MRI have a comparable risk of missing significant prostate cancer in men with PSA less than 10ng/ml and normal DRE, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/23

  9. Nakayama T., Saito K., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N, Kihara K.. Prognostic comparison of serum biomarkers for cancer-specific survival of renal cell carcinoma undergoing nephrectomy: C-reactive protein has the highest predictive ability on survival, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/21

  10. Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal number of sampling cores in MRI-targeted biopsy, Madrid, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/21

  11. Fukushima H., Koga F., Nakanishi Y., Tobisu K.. Prognostic impact of intensive local therapy to bone lesions in renal cell carcinoma patients with bone metastasis, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/21

  12. Fukushima H., Koga F., Nakanishi Y., Tobisu K.. Prognostic significance of sarcopenia in metastatic renal cell carcinoma: Its association with survival benefit from cytoreductive nephrectomy, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/21

  13. Fujii, Y., Kihara, K., Numao, N., Matsuoka, Y., Ishioka, J., Saito, K. . Gasless single-port RoboSurgeon partial cystectomy: A hybrid technique combining an intravesical and extravesical approach, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/22

  14. Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K.. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/22

  15. Fujii, Y., Moriyama S., Yokoyama M., Yonese J., Noro A., Arisawa C., Morimoto S., Okuno T., Kitahara S., Koga F., Sakai Y., Suzuki M., Nagahama K., Izutani T., Saito K., Kihara K.. Bladder neck involvement predicts progression in patients with primary non-muscle-invasive bladder cancer: A multicenter validation study, The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/23

  16. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Yokoyama M, Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K.. A novel three-dimensional image display system for transurethral surgery , The 30th Annual Congress of the European Association of Urology, Madrid, Spain, 2015/3/23

2014年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Fukushima H, Yokoyama M, Koga F Sarcopenia is a prognostic biomarker of advanced urothelial carcinoma. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/19

  2. Fukushima H, Yoshida S, Koga F, Nakanishi Y, Kijima T, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K Reduced TRAP1 expression is associated with poor prognosis in upper urinary tract urothelial carcinoma patients: its implications for tumor invasion. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/18

  3. Higuchi S, Kijima T, Nakanishi Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K. Antimicrobial prophylaxis is avoidable in minimally invasive nephroureterectomy with negative urine culture. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/17

  4. Inoue M, Koga F, Yoshida S, Kijima T, Nakanishi Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K. ErbB2 overexpression is relevant to therapeutic resistance and poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder-sparing protocol. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/18

  5. Ishikawa Y, Numao N, Ishii C, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Identification of patients who can avoid repeat biopsy using multiparametric magnetic resonance imaging. The 108th annual meeting of the American Urological Association Orlando, USA, 2014/5/20

  6. Ito M, Numao N, Nakanishi Y, Kijima T, Yoshida S, Ishioka J, Mastuoka Y, Saito K, Fujii Y, Kihara K. Biopsy Gleason score 3+4 may be included as criteria for active surveillance after 2005 International Society of Urological Pathology consensus. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/20

  7. Kijima T, Kihara K, Fujii Y, Koga F, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy and consolidative partial cystectomy in muscle invasive bladder cancer patients with synchronous or metachronous multifocality. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/19

  8. Kihara K, Saito K, Nakanishi Y, Kijima T, Yoshida S, Ishioka J, Mastuoka Y, Numao N, Koga F, Masuda H, Fujii Y. Favorable outcomes of gasless single-port clampless partial nephrectomy using new three dimensional head-mounted display system (RoboSurgeon system). The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/17

  9. Numao N, Matsuoka Y, Ito M, Yoshida S, Ishikawa Y. Uchida Y, Toide M, Higuchi S, Nakayama T, Inoue M, Takeshita H, Kijima T, Nakanishi Y, Ishioka J, Saito K, Fujii Y, Kihara K Potential of additional magnetic resonance imaging (MRI)-targeted prostate biopsy to avoid underestimation of systematic 14-core biopsy. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/18

  10. Takeshita H, Kihara K, Masuda H, Koga F, Nakanishi Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y. Bladder-Sparing Therapy in Muscle-Invasive Bladder Cancer by Induction Chemoradiotherapy plus Partial Cystectomy with Pelvic Lymph Node Dissection: Assessments of Quality of Life and Urinary Functions. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/19

  11. Tanaka H, Yoshida S, Komai Y, Hayashi T, Sakura M, Urakami S, Sakai Y, Yuasa T, Yamamoto S, Masuda H, Fukui I, Yonese J, Fujii Y, Kihara K The value of 18F-FDG PET/CT in staging of upper tract urothelial carcinoma: impact on patient management. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/16

  12. Yoshida S, Koga F, Tanaka H, Satoh S, Nakanishi Y, Kijima T, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K Diffusion-weighted MRI for assessing the response of muscle-invasive bladder cancer to chemoradiotherapy. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/17

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Inoue M, Koga F, Yoshida S, Kijima T, Nakanishi Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K. ErbB2 overexpression predicts chemoradiotherapy resistance and worse prognosis in muscle-invasive bladder cancer patients treated with induction chemoradiotherapy followed by partial or radical cystectomy The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  2. Inoue M, Numao N, Ito M, Takeshita H, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Impact of androgen deprivation therapy on cardiovascular disease in patients with non-metastatic high-risk prostate cancer The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/14

  3. Ishikawa Y, Numao N, Ishii C, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Potential of prebiopsy MRI to reduce biopsies in men with suspected clinically localized prostate cancers in the repeat biopsy setting The 29th Annual Congress of the European Association of Urology Stockholm, Sweden, 2014/4/14

  4. Ishioka J, Kihara K, Fujii Y, Saito K, Masuda H, Koga F. Numao N, Matsuoka Y, Yoshida S, Takeshita H, Higuchi S, Nakayama T. New head-mounted display system applied to endoscopic management off urothelial cancers The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2013/4/14

  5. Kihara K, Fujii Y, Saito K, Masuda H, Koga F, Numao N, Ishioka J, Matsuoka Y, New 3-dimensional head-mounted display system (RoboSurgeon System) applied to gasless, two-port access total nephroureterectomy. "Highlights and awards section" The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  6. Koga F., Inoue M., Kijima T., Yoshida S., Ishioka J., Matsuoka Y., Numao N., Saito K., Masuda H., Fujii Y., Kihara K. Pre-therapeutic risk stratification of muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  7. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Fujii Y, Kihara K. Topographical risk stratification of undertreatment in focal therapy for prostate cancer: Mid-apical biopsy compensates for MRI underdiagnosis. The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  8. Numao N, Matsuoka Y, Ito M, Yoshida S, Ishikawa Y. Uchida Y, Toide M, Higuchi S, Nakayama T, Inoue M, Takeshita H, Kijima T, Nakanishi Y, Ishioka J, Saito K, Fujii Y, Kihara K Direct comparison of the ability to detect significant prostate cancer and assess cancer characteristics between magnetic resonance imaging targeted biopsy and systematic 14-core biopsy, including anterior samplings The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/14

  9. Takeshita H, Kihara K, Masuda H, Koga F, Nakanishi Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y. Favourable quality of life and urinary functions after bladder preservation in muscle-invasive bladder cancer patients treated with induction chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection. The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/12

  10. Yoshida S, Kihara K, Takeshita T, Inoue M, Nakanishi Y, Kijima T, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y Head-mounted display-based personal integrated-image monitoring system for TURP The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

2013年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Kihara K, Takeshita H, Masuda H, Koga F, Saito K, Matsuoka Y, Numao N, Fujii Y. Novel three-dimensional head-mounted display system (RoboSurgeon System) : application to the initial 80 cases of gasless single-port access urologic surgeries. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  2. Yachida Y, Takeshita H, Sawamura C, Tanaka H, Sato S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Fujii Y, Kihara K. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspicious of prostate cancer; what does the signal reflect? The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/8

  3. Matsuoka Y, Ishioka J, Numao N, Tanaka H, Yoshida S, Yokoyama M, Koga F, Saito K, Masuda H, Fujii Y, Kihara K. Impact of MRI on the prediction of side-specific extracapsular extension: Nomogram based on tumor contact length and percent positive biopsy cores. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/5

  4. Matsuoka Y, Numao N, Saito K, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Koga F, Masuda H, Fujii Y, Kihara K. Combination of extended biopsy and MRI identifies candidates for quadrant-ablation focal therapy of prostate cancer. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  5. Fujii Y, Yamamoto S, Yonese J, Masuda H, Urakami S, Kitsukawa S, Kihara K, Fukui I. Long-term results of the processus vaginalis transection method to prevent postradical prostatectomy inguinal hernia. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  6. Numao N, Magnetic resonance imaging guided prostate biopsy versus systematic 14-core prostate biopsy including anterior samplings in detecting significant cancer and assessing cancer aggressiveness. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  7. Numao N, Potential of prebiopsy multiparametric magnetic resonance imaging to reduce initial biopsies in men with suspected clinically localized prostate cancer. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  8. Nakanishi Y, Komai Y, Masuda H, Matsuoka Y, Numao N, Yoshimoto T, Saito K, Koga F, Fujii Y, Ogawa Y, Kihara K The abnormality of glucose tolerance test in pheochromocytoma: one of the significant findings of postoperative hypoglycemia. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  9. Koga F, Kobayashi S, Fujii Y, Yokoyama M, Nakanishi Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H, Kihara K. Prognostic significance of positive urine cytology in non-muscle invasive bladder cancer patients. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  10. Koga F, Fujii Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H, Kawakami S, Kihara K. Predictors of intravesical tumor recurrence following selective bladder preservation in muscle-invasive bladder cancer patients. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  11. Ishioka J, Saito K, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Sakai Y, Okuno T, Arisawa C, Kamata S, Nagahama K, Yonese J, Noro A, Tsujii T, Morimoto S, Kitahara S, Goto S, Higashi Y, Kihara K. Risk stratification for bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  12. Ishioka J, Masuda H, Matsuoka Y, Numao N, Koga F, Saito K, Fujii Y, Sakai Y, Okuno T, Arisawa C, Kamata S, Nagahama K, Yonese J, Noro A, Tsujii T, Morimoto S, Kitahara S, Goto S, Higashi Y, Kihara K. Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients: Multi-center study in a 1114-case Tokyo Metropolitan Database of Urologic Disease (TMDU) cohort. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

  13. Kijima T, Koga F, Fujii Y, Yoshida S, Tatokoro M, Kihara K. Radiosensitizing effect of zoledronic acid on renal cell carcinoma cells by downregulating STAT1. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/5

  14. Takeshita H, Masuda H, Saito K, Tanaka H, Komai Y, Sakai Y, Koga F, Yonese J, Noro A, Kawakami S, Yamada T, Fujii Y, Kihara K. Serum C-reactive protein as an indicator of survival after surgery for adrenal metastasis from multiple primary sites. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/4

  15. Waseda Y, Saito K, Ishioka J, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Sakai Y, Okuno T, Arisawa C, Kamata S, Nagahama K, Yonese J, Noro A, Tsujii T, Morimoto S, Higashi Y, Fukui I, Kihara K. Presence of ureteral tumor was associated with poor prognosis in upper urinary tract urothelial carcinoma patients treated by nephroureterectomy: a multicenter database study of 1063 patients. The 107th annual meeting of the American Urological Association, San Diego, USA, 2013/5/6

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Kihara K, Takeshita H, Masuda H, Koga F, Saito K, Matsuoka Y, Numao N, Fujii Y. Novel three-dimensional head-mounted display system (RoboSurgeon System) : application to initial 60 cases of gasless single-port access urologic surgeries. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  2. Kihara K, Fujii Y, Masuda H, Saito K, Koga F, Numao N, Matsuoka Y. New 3-dimensional head-mounted display system (RoboSurgeon system) applied to gasless, single-port access adrenalectomy. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  3. Kihara K, Fujii Y, Masuda H, Saito K, Koga F, Numao N, Matsuoka Y. New 3-dimensional head-mounted display system (RoboSurgeon system) applied to gasless, single-port access, clampless partial nephrectomy. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  4. Yoshida S, Kobayashi S, Koga F, Ishioka J, Ishii C, Tanaka H, Nakanishi Y, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K. The ADC value is a prognostic biomarker of upper urinary tract cancer: Potential application to preoperative risk stratification. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/16

  5. Fukushima H, Saito K, Ishioka J, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Sakai Y, Arisawa C, Okuno T, Yonese J, Kamata S, Nagahama K, Akira Noro, Morimoto S, Tsujii T, Kitahara S, Gotoh S, Higasi Y, Kihara K. Equivalent survival after distal ureterectomy compared to nephroureterectomy in patients with urothelial carcinoma of the distal ureter: A propensity score-matched multi-center study. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/16

  6. Matsuoka Y, Ishioka J, Numao N, Tanaka H, Yoshida S, Yokoyama M, Koga F, Saito K, Masuda H, Fujii Y, Kihara K. Simple prediction model of side-specific extracapsular extension based on percent positive biopsy cores and tumor contact length with the capsule on MRI. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  7. Matsuoka Y, Numao N, Saito K, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Koga F, Masuda H, Fujii Y, Kihara K. Candidate selection for quadrant-ablation focal therapy of prostate cancer through a combination of extended 14-core biopsy and MRI. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  8. Fujii Y., Kobayashi S., Koga F., Yokoyama M., Yoshida S., Ishioka J., Matsuoka Y., Numao N., Saito K., Masuda H., Kihara K. Prediction of progression in patients with non-muscle invasive bladder cancer based on histologic grade, T stage, recurrence rate and bladder neck involvement: the BN-GTR model. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  9. Koga F, Fujii Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H, Kawakami S, Kihara K. Risk factors for intravesical tumor recurrence in muscle-invasive bladder cancer patients treated with selective bladder-sparing approaches. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  10. Saito K, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Hayashi K, Shibuya H, Kihara K. Focal therapy for prostate cancer using I125seed implantation: Hemiablative brachytherapy for patients selected using extended biopsy and MRI. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  11. Ishioka J, Saito K, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Sakai Y, Okuno T, Arisawa C, Kamata S, Nagahama K, Yonese J, Noro A, Tsujii T, Morimoto S, Higashi Y, Fukui I, Kihara K. Risk stratification model for predicting bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

  12. Kijima T, Koga F, Fujii Y, Yoshida S, Tatokoro M, Kihara K. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. The 28th Annual Congress of the European Association of Urology, Milan, Italy, 2013/3/17

2012年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Kihara K, Koga F, Masuda H, Saito K, Tatokoro M, Yokoyama M, Matsuoka Y, Numao N, Kawakami S, Fujii Y. Gasless single-port clampless partial nephrectomy for peripheral renal tumor: Surgical, short-term oncological, and functional outcomes. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  2. Kihara K, Masuda H, Saito K, Koga F, Numao N, Matsuoka Y, Ishioka J, Yokoyama M, Sakura M, Fujii Y. Gasless laparoendoscopic single-port retroperitoneal radical nephrectomy in dialysis patients: perioperative outcomes of 82 consecutive cases. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  3. Yokoyama M, Fujii Y, Takeshita H, Sakura M, Ishioka J, Iimura Y, Saito K, Koga F, Masuda H, Noro A, Kihara K. Development and validation of predictive models for renal function after radical nephrectomy. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  4. Yokoyama M, Fujii Y, Takeshita H, Iimura Y, Saito K, Koga F, Masuda H, Noro A, Kihara K. Longitudinal recovery of renal function up to 10 years after radical nephrectomy The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  5. Takeshita H, Numao N, Kawakami S, Sakura M, Yokoyama M, Ishioka J, Matusoka Y, Koga F, Saito K, Masuda H, Yamamoto S, Yonese J, Ishikawa Y, Fukui I, Kihara K. Characteristics of prostate cancers missed by initial transperineal extended biopsy The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/23

  6. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Kobayashi S, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Koga F, Masuda H, Kihara K. Combination of 14-core biopsy and magnetic resonance imaging can identify appropriate candidates for hemiablative focal therapy of prostate cancer. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/20

  7. Numao N, Yoshida S, Komai Y, Ishii C, Kagawa M, Matsuoka Y, Koga F, Saito K, Masuda H, Kawakami S, Kihara K Prebiopsy multi-parametric MRI potentially reduces unnecessary prostate biopsy in men with PSA less than 10 ng/mL and a normal digital rectal examination. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  8. Masuda H, Kawakami S, Ito M, Takeshita H, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yamamoto S, Fukui I, Kihara K. Performance of free PSA mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  9. Kagawa M, Masuda H, Kawakami S, Ito M, Takeshita H, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yamamoto S, Fukui I, Kihara K. Better performance of plasma volume than body mass index for high-grade prostate cancer detection at extended biopsy in Japanese men. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  10. Tatokoro M, Masuda H, Kijima T, Yoshida S, Sakura M, Yokoyama M, Saito K, Koga F, Kawakami S, Fujii Y, Kihara K. Successful control of Methicillin-resistant Staphylococcus aureus in a urology ward possibly due to avoidance of antimicrobial prophylaxis in minimally invasive surgery: our 11 years trial. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

  11. Kijima T, Masuda H, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Kihara K. Antimicrobial prophylaxis is not necessary in minimally invasive partial nephrectomy without entry into the urinary tract. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Kihara K, Koga F, Masuda H, Saito K, Tatokoro M, Yokoyama M, Matsuoka Y, Numao N, Kawakami S, Fujii Y. Feasibility of gasless single‐port clampless partial nephrectomy for peripheral renal tumor: An experience of 118 consecutive cases. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

  2. Kihara K, Masuda H, Saito K, Koga F, Numao N, Matsuoka Y, Ishioka J, Yokoyama M, Sakura M, Fujii Y. Gasless laparoendoscopic single-port retroperitoneal radical nephrectomy for renal tumors in dialysis patients: perioperative outcomes of 81 consecutive cases. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

  3. Yokoyama M, Fujii Y, Takeshita H, Sakura M, Ishioka J, Iimura Y, Saito K, Koga F, Masuda H, Noro A, Kihara K. Novel nomogram and formula to predict renal function after radical nephrectomy. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

  4. Takeshita H, Yokoyama M, Fujii Y, Chiba K, Ishioka J, Saito K, Koga F, Masuda H, Noro A, Kihara K. Impact of renal function immediately after radical nephrectomy on cardiovascular events in patients with kidney cancer. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

  5. Sakura M, Masuda H, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Koga F, Saito K, Kihara K. Can diffusion weighted magnetic resonance imaging detect renal cell carcinoma in dialysis patient with acquired cystic disease of kidney? The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

  6. Kawakami S,

  7. Numao N, Yoshida S, Komai Y, Ishii C, Kagawa M, Takeshita H, Nakanishi Y, Kijima T, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Matsuoka Y, Koga F, Saito K, Masuda H, Kawakami S, Kihara K Prebiopsy multi-parametric MRI can substantially reduce unnecessary prostate biopsy in men with PSA less than 10 ng/mL and a normal digital rectal examination. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

  8. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Kobayashi S, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Koga F, Masuda H, Kihara K. Candidate selection for hemiablative focal therapy of prostate cancer through a combination of extended 14-core biopsy and MRI. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

  9. Fukushima H, Masuda H, Kawakami S, Ito M, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yonose J, Fukui I, Kihara K. Positive association between diabetes mellitus and high grade prostate cancer detection via extended prostate biopsy in obese Japanese men with PSA less than 10 ng/ml. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

  10. Koga F, Yoshida S, Kobayashi S, Ishii C, Tanaka H, Fujii Y, Tanaka H, Masuda H, Saito K, Komai Y, Kawakami S, Kihara K. Diffusion‐weighted MRI predicts sensitivity to chemoradiation in muscle‐invasive bladder cancer. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

  11. Tatokoro M, Koga F, Yoshida S, Fukushima H, Kawakami S, Fujii Y, Neckers L, Kihara K. Potential role of Hsp90 Inhibitors in overcoming cisplatin resistance of bladder cancer stem cells. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/26.

  12. Kobayashi S, Fujii Y, Koga F, Yokoyama M, Sakura M, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H, Kihara K. Impact of bladder neck involvement on progression in patients with non-muscle invasive bladder cancer: a validation study. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

  13. Tatokoro M, Masuda H, Kijima T, Yoshida S, Sakura M, Yokoyama M, Saito K, Koga F, Fujii Y, Kawakami S, Kihara K. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus Aureus (MRSA) in a urology ward possibly due to avoidance of antimicrobial prophylaxis in minimally invasive surgery: Our 11-year trial. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

  14. Kijima T, Masuda H, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Kihara K. Antimicrobial prophylaxis is avoidable in minimally invasive partial nephrectomy without entry into the urinary tract. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

米国臨床癌学会泌尿生殖器癌シンポジウム(American Society of Clinical Oncology, Genitourinary Cancers Symposium)
  1. Ishioka J, Saito K, Sakura M, Yokoyama M, Matsuoka Y, Numao N, Koga F, Masuda H, Kihara K. A contribution of C-reactive protein to predict overall survival in patients with advanced urothelial carcinoma: Development of a nomogram and evaluation by decision curve analysis. The 2012 Genitourinary Cancer Symposium, San Francisco, CA, 2012/2/2.

2011年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Fujii Y, Sakura M, Saito K, Iimura Y, Yasuda Y, Koga F, Masuda H, Kawakami S, Yonese J, Fukui I, Kihara K. NOMOGRAM TO PREDICT MINIMAL-FAT ANGIOMYOLIPOMA AT NEPHRECTOMY FOR RENAL MASSES PRESUMED TO BE STAGE 1 RENAL CELL CARCINOMA: IMPACT OF SEX, AGE, AND TUMOR SIZE The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  2. Kagawa M, Yoshida S, Numao N, Komai Y, Sakura M, Okada Y, Koga F, Saito K, Masuda H, Fujii Y, Ishii C, Kawakami S, Kihara K. Can men with a normal digital rectal examination and with negative findings on pre-biopsy multi-parametric magnetic resonance imaging avoid immediate prostate biopsy? The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  3. Kijima T, Yoshida S, Tatokoro M, Araki S, Yokoyama M, Numao N, Okada Y, Saito K, Koga F, Masuda H, Fujii Y, Kihara K. Antibiotic prophylaxis is not necessary in minimally invasive surgery for renal and adrenal tumors: A prospective study of 301 consecutive patients The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  4. Kobayashi S, Yoshida S, Koga F, Ishii C, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Diffusion-Weighted magnetic resonance imaging reflects pathologic phenotypes of bladder cancer The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  5. Koga F, Totokoro M, Kijima T, Sakura M, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Sensititivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  6. Koga F, Yokoyama M, Ishioka J, Numao N, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiation in bladder-sparing protocol The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  7. Komai Y, Numao N, Yoshida S, Kawakami S, Ishii C, Sakura M, Okada Y, Koga F, Saito K, Masuda H, Fujii Y, Kihara K. Multi-parametric magnetic resonance imaging can detect prostate cancers missed by transrectal 12-core biopsy with high accuracy The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  8. Numao N, Kawakami S, Sakura M, Komai Y, Yokoyama M, Okada Y, Koga F, Saito K, Masuda H, Fujii Y, Yamamoto S, Yonese J, Ishikawa Y, Fukui I, Kihara K. Negative result in unilateral 13-core biopsy can predict the absence of significant cancer on the ipsilateral lobe with a high accuracy. Implications for hemiablative focal therapy. The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  9. Tanaka H, Yoshida S, Fujii Y, Ishii C, Koga F, Saito K, Masuda H, Kawakami S, Kihara K. Diffusion-Weighted Magnetic Resonance Imaging in Differentiation of Angiomyolipoma with Minimal Fat from Clear Cell Renal Cell Carcinoma The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  10. Yasuda Y, Saito K, Sukegawa G, Ito M, Kubo Y, Yano A, Kitsukawa S, Yuasa T, Urakami S, Yamamoto S, Yonese J, Takahashi S, Fukui I. Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  11. Yokoyama M, Fujii Y, Iimura Y, Saito K, Koga F, Masuda H, Kihara K. A nomogram for predicting the development of chronic kidney disease within 2 years after radical nephrectomy in patients with renal cortical tumor The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  12. Yoshida S, Kobayashi S, Koga F, Ishii C, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Diffusion-Weighted Magnetic Resonance Imaging Reflects Pathologic Phenotypes of Bladder Cancer The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

  13. Yoshida S, Koga F, Tatokoro M, Kawakami S, Fujii Y, Kumagai J, Neckers L, Kihara K. Hsp90 inhibitors potentially overcome chemoradiotherapy resistance associated with HER-2 and NFκB overexpression in muscle-invasive bladder cancer The 105th annual meeting of the American Urological Association, Washington DC, USA, 2011/5/14-19

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Araki S, Sakura M, Tatokoro M, Yoshida S, Yokoyama M, Saito K, Koga F, Masuda H, Fujii Y, Kawakami S, Kihara K. A single-dose administration of antibiotic prophylaxis in minimally invasive radical prostatectomy; a prospective study of 300 consecutive cases. The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  2. Kobayashi S, Yoshida S, Koga F, Ishii C, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Diffusion-Weighted Magnetic Resonance Imaging Reflects Clinical Aggressiveness of Bladder Cancer The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  3. Koga F, Yoshida S, Tatokoro M, Kawakami S, Fujii Y, Kumagai J, Neckers L, Kihara K. Potential role of Hsp90 inhibitors to overcome chemoradiotherapy resistance associated with HER-2 and NFκB overexpression in muscle-invasive bladder cancer The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  4. Koga F, Yokoyama M, Ishioka J, Numao N, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Who are at high-risk for cancer death among muscle-invasive bladder cancer patients treated with chemoradiation-based bladder-sparing protocols? The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  5. Komai Y, Numao N, Yoshida S, Sakura M, Okada Y, Ishii C, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. High diagnostic ability of multi-parametric magnetic resonance imaging in detecting prostate cancers missed by transrectal 12-core biopsy The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  6. Masuda H, Kawakami S, Sakura M, Fujii Y, Koga F, Saito K, Numao N, Yoshida S, Komai Y, Okada Y, Ito M, Yonese J, Fukui I, Kihara K. Performance of free PSA better than total PSA for estimation of prostate volume in elderly men without prostate cancer The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  7. Numao N, Kawakami S, Sakura M, Komai Y, Yokoyama M, Okada Y, Koga F, Saito K, Masuda H, Fujii Y, Yamamoto S, Yonese J, Ishikawa Y, Fukui I, Kihara K. Patient selection for hemiablative focal therapy of prostate cancer based on extended 14- or 26-core biopsy The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  8. Saito K, Ito M, Kijima T, Numao N, Koga F, Masuda H, Fujii Y, Kawakami S, Urakami S, Yuasa T, Yamamoto S, Yonese J, Fukui I, Kihara K. Impact of C-reactive protein kinetics on survival of castration-resistant prostate cancer patients treated with docetaxel The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  9. Tatokoro M, Fujii Y, Kawakami S, Saito K, Koga F, Masuda H, Kihara K. Phase-II trial of combination treatment of interferon-alfa, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA) for metastatic renal cell carcinoma. The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

  10. Yokoyama M, Fujii Y, Iimura Y, Saito K, Koga F, Masuda H, Kihara K. Significant recovery of renal function following radical nephrectomy in Japanese patients: A retrospective longitudinal study The 26th Annual Congress of the European Association of Urology, Vienna, Austria, 2011/3/18-22

米国臨床癌学会泌尿生殖器癌シンポジウム(American Society of Clinical Oncology, Genitourinary Cancers Symposium)
  1. Fujii Y, Saito K, Iimura Y, Yasuda Y, Koga F, Masuda H, Yonese J, Ishikawa Y, Fukui I, Kihara K. INCIDENCE OF BENIGN PATHOLOGIC LESIONS AT NEPHRECTOMY FOR RENAL MASSES PRESUMED TO BE STAGE 1 RENAL CELL CARCINOMA IN JAPANESE PATIENTS: IMPACT OF SEX, AGE AND TUMOR SIZE. The 2011 Genitourinary Cancers Symposium, Orland, USA, 2011/2/17-19

  2. Iimura Y, Saito K, Fujii Y, Ishioka J, Iwai A, Numao N, Okada Y, Koga F, Masuda H, Kihara K. Use of C-reactive protein to predict perinephric or renal sinus fat invasion in patients with clinical T1N0M0 renal cell carcinoma The 2011 Genitourinary Cancers Symposium, Orland, USA, 2011/2/17-19

  3. Iwai A, Koga F, Kawakami S, Fujii Y, Masuda H, Saito K, Kihara K. Does induction chemoradiothepy compromise subsequent radical cystectomy? A single-institutional comparative study of perioperative complications according to the Clavien-Dindo classification. The 2011 Genitourinary Cancers Symposium, Orland, USA, 2011/2/17-19

  4. Okada Y, Masuda H, Saito K, Iimura Y, Yokoyama M, Komai Y, Numao N, Koga F, Fujii Y, Kihara K. Surgical outcomes of gasless single port retroperitoneal radical nephrectomy for dialysis patients: A comparative analysis with non-dialysis patients. The 2011 Genitourinary Cancers Symposium, Orland, USA, 2011/2/17-19

  5. Saito K, Kihara K, Numao N, Masuda H, Kijima T, Tatokoro M, Koga F, Fujii Y, Hayashi K, Shibuya H. Initial experience of focal therapy for prostate cancer using I-125 seed implantation: Unilateral ablation for patients selected by extended biopsy and MRI findings. The 2011 Genitourinary Cancers Symposium, Orland, USA, 2011/2/17-19

  6. Sakura M, Kawakami S, Ishioka J, Fujii Y, Yamamoto S, Iwai A, Numao N, Saito K, Koga F, Masuda H, Kumagai J, Yonese J, Fukui I, Kihara K. A novel repeat biopsy nomogram based on three-dimensional extended biopsy The 2011 Genitourinary Cancers Symposium, Orland, USA, 2011/2/17-19

  7. Tatokoro M, Saito K, Fujii Y, Komai Y, Koga F, Masuda H, Kawakami S, Kihara K C-reactive protein kinetics superior to radiographic response as a surrogate endpoint for survival in patients with advanced renal cell carcinoma. The 2011 Genitourinary Cancers Symposium, Orland, USA, 2011/2/17-19

2010年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Fujii Y, Komai Y, Saito K, Yasuda Y, Koga F, Masuda H, Yonese J, Kawakami S, Kumagai J, Ishikawa Y, Fukui I, Kihara K. Low incidence of being pathologic lesions at nephrectomy for renal masses presumed to be stage T1N0M0 renal cell carcinoma in Japanese patients : influence of sex, age and tumor size. The 104th annual meeting of the American Urological Association, San Francisco, 2010/3/29.

  2. Fukui N, Kageyama Y, Kohno Y, Inoue M, Higashi Y,Kizaka-Kondoh S, Hiraoka M. Development of hypoxia-responsive interferon alpha 2b gene constructs and their suppressive effects on human renal cell carcinoma cell lines in vitro.  The 104th annual meeting of the American Urological Association, San Francisco, 2010/5/30.

  3. Masuda H, Kawakami S, Fujii Y, Koga F, Saito K, Numao N, Kijima T, Yoshida S, Yamamoto S, Yonese J, Fukui I, Kihara K. Performance of free PSA better than total PSA for estimation of prostate volume in elderly men without prostate cancer. The 104th annual meeting of the American Urological Association, San Francisco, USA, 2010/5/29.

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Kawakami S, Takeshita H, Tatokoro M, Yamamoto S, Kijima T, Komai Y, Saito K, Numao N, Koga F, Fujii Y, Fukui I, Kihara K. Diagnostic performance of a three-dimensional 14-core systematic biopsy which can detect more than 95% of the prostate cancers detected by the three-dimensional 26-core super-extended biopsy scheme. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  2. Kihara K, Tsushima T, Kawakami S, Fujii Y, Masuda H, Saito K, Koga F. Gasless, single port access, ultrasound guided, clampless partial nephrectomy: MIES partial nephrectomy. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  3. Kijima T, Kawakami S, Yano A, Okada Y, Sakai Y, Saito K, Koga F, Masuda H, Fujii Y, Kihara K. Docetaxel is effective to estrogen refractory prostate cancer but not to estrogen-and glucocorticoid-refractory prostate cancer. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/19.

  4. Kobayashi S, Yoshida S, Koga F, Ishii C, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Feasibility of Diffusion-Weighted Magnetic Resonance Imaging in diagnosis of Bladder Cancer. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, Apr 17, 2010.

  5. Koga F, Kihara K, Yoshida S, Saito K, Masuda H, Fujii Y, Kawakami S. Partial cystectomy after induction chemoradio therapy possibly improves oncological outcomes of selective bladder-sparing protocol against muscle-invasive bladder cancer. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  6. Koga F, Fukushima H, Kawakami S, Fujii Y, Yoshida S, Ratovitski E, Trink B, Kihara K. Loss of p63 (⊿NP63α) promotes invasion of urothelial carcinomas. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/19.

  7. Komai Y, Kawakami S, Numao N, Fujii Y, Saito K, Koga F, Yamamoto S, Yonese J, Fukui I, Kihara K. Extended biopsy- based criteria for predicting clinically insignificant prostate cancer. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/18.

  8. Kubo Y, kawakami S, Numao N, Kitayama S, Takazawa R, Yokoyama M, Saito K, Uragami S, Yamamoto S, Fujii Y, Yonese J, Tujii T, Fukui I, Kihara K. A simple and effective local anesthetic method for three-dimensional extended prostate biopsy: a prospective confirmatory study with an expanded cohort. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  9. Numao N, kawakami S, Kubo Y, Yamamoto S, Yonese J, Kihara K, Fukui I. Should we change number of sampling cores according to clinical variables at an initial prostate biopsy? The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  10. Saito K, Kihara K, Kawakami S, Fujii Y, Masuda H, Koga F. Gasless two port access total nephroureterectomy: MIES total nephroureterectomy, The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  11. Saito K, Urakami S, Komai Y, Kijima T, Sukegawa G, Ito M, Kubo Y, Suyama T, Kitsukawa S, Okubo Y, Yamamoto S, Yonese J, Fukui I. The impact of C-reactive protein kinetics on survival in patients with advanced urothelial carcinoma treated with gemcitabine, etoposide and cisplatin. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  12. Yokoyama M, kawakami S, Numao N, Fujii Y, Koga F, Saito K, Yonese J, Yuichi Y, Fukui I, Kihara K. Smaller prostate volume is a risk factor of high grade prostate cancer detected by the three-dimensional 26- core biopsy. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

  13. Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Numao N, Saito K, Koga F, Fujii Y, Kawakami S, Kihara K. Diffusion-weighted magnetic resonance imaging in diagnosis of upper urinary tract cancer. The 25th Anniversary Congress of the European Association of Urology, Barcelona, Spain, 2010/4/17.

米国臨床癌学会泌尿生殖器癌シンポジウム(American Society of Clinical Oncology, Genitourinary Cancers Symposium)
  1. Kijima T, Kawakami S, Okada Y, Sakai Y, Saito K, Koga F, Masuda H, Fujii Y, Kihara K. Activity of docetaxel against estrogen-refractory prostate cancer and against estrogen- and glucocorticoid-refractory prostate cancer. The 2010 Genitourinary Cancer Symposium, San Francisco, USA, 2010/3/5.

  2. Koga F, Kihara K, Yoshida S, Saito K, Masuda H, Fujii Y, Kawakami S. Selective bladder-sparing protocol by induction low-dose chemoradiotherapy plus partial cystectomy against muscle-invasive bladder cancer. The 2010 Genitourinary Cancer Symposium, San Francisco, USA, 2010/3/6.

その他の国際学会
  1. Huang T, Kohno Y, Fukui N, Kageyama Y, Higashi Y. A single intravesical instilation of pirarubicin immediately after TUR-Bt decreases short term recurrences in patients with pTa/pT1 bladder cancer: The outcome in Saitama Cancer Center. The 20th Annual Meeting of the International Urological Conference of Taiwan, Taipei, Taiwan, 2010/10/13.

  2. Kitayama S, Takazawa R, Tsujii T. Impact of prostate volume on the efficacy of solifenacin succinate monotherapy in men with lower urinary tract symptoms and overactive bladder symptoms. The 30th SIU World Meeting, Marrakech, Morocco, 2010/10/15.

  3. Masuda H, Kawakami S, Fujii Y, Koga F, Saito K, Yonese J, Fukui I, Kihara K. Performance of free PSA better than total PSA for estimation of prostate volume in elderly men without prostate cancer. Nagoya Shinshu Forum 2010, Matsumoto, Japan, 2010/10/2.

  4. Masuda H, Kawakami S, Fujii Y, Koga F, Saito K, Yonese J, Fukui I, Kihara K. Correlation of lower urinary tract symptoms with Gleason score and transition zone volume in prostate cancer patients. Nagoya Shinshu Forum 2010, Matsumoto, Japan, 2010/10/2.

2009年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Fujii Y, Yamamoto S, Yonese J, Kawakami S, Suyama T, Komai K, Kijima T, Kihara K, Fukui I. Novel technique to prevent post-radical retropubic prostatectomy inguinal hernia: the processus vaginalis transection method. 104th annual meeting of AUA (AUA 2009). Chicago, USA, 2009/4/28.

  2. Iimura Y, Saito K, Fujii Y, Kumagai J, Komai Y, Tatokoro M, Kawakami S, Yonese J, Fukui I, Kihara K. Preoperative C-reactive protein is a significant factor of recurrence prediction model in patients with nonmetastatic clear cell renal cell carcinoma. 104th annual meeting of AUA (AUA 2009). Chicago, USA, 2009/4/28.

  3. Komai Y, Fujii Y, Yoshida S, Tatokoro M, Iimura Y, Saito K, Otsuka Y, Kawakami S, Okuno T, Tsujii T, Morimoto S, Toma T, Ando M, Higashi Y, Fukui I, Kihara K. Young age is an independent favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma patients. The 97th annual meeting of the American Urological Association, Chicago, 2009/4/24.

  4. Minato Yokoyama, Yasuhisa Fujii, Yasumasa Iimura, Hitoshi Masuda, Satoru Kawakami, Kazunori Kihara.Estimated glomerular filtration rate after radical or partial nephrectomy in Japanese patients with renal cortical tumors. 104th annual meeting of AUA (AUA 2009).Chicago, USA, 2009/4/28.

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Kawakami S. Repeat biopsy indicators: Novel nomograms based on extended repeat biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

  2. Kihara K, Kawakami S, Fujii Y, Masuda H, Koga F, Saito K. Gasless single port access radical nephrectomy. EAU Annual Congress, Stockholm, 2009/3/19.

  3. Masuda H, Yoshida S, Yokoyama M, Kihara K, De Groat WC, Chancellor MB, Yoshimura N. Time course changes in nitric oxide synthase isoforms in the spinal cord following induction of cystitis in the rats. EAU Annual Congress, Stockholm, 2009/3/19.

  4. Masuda H, Sakai S, Numao N, Komai Y, Tatokoro M, Kihara K. Urinary hydrogen peroxide: A probable marker of oxidative stress as a biomarker of cyctitis. EAU Annual Congress, Stockholm, 2009/3/18.

  5. Masuda H, Sakai Y, Matsuoka Y, Yokoyama M, Ichiyanagi N, Azuma H, Kihara K. Therapeutic effects of phosphodiesterase type 5 inhibitor on bladder blood flow and nitric oxide pathway in the rat urinary bladder after partial outlet obstruction. EAU Annual Congress, Stockholm, 2009/3/19.

  6. Numao N. Kawakami S, Fujii Y, Masuda H, Koga F, Sakai Y, Yonese J, Ishikawa Y, Fukui I, Kihara K. Candidate selection for focal targeted therapy with unilateral lobe by three-dimensional 26-core prostate biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

  7. Numao N. Kawakami S, Fujii Y, Masuda H, Koga F, Sakai Y, Yonese J, Ishikawa Y, Fukui I, Kihara K. Characterization of prostate cancers missed by transrectal 12-core biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

  8. Yano A. Fujii Y, Iwai A, Kawakami S, Kageyama Y, Kihara K. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. EAU Annual Congress, Stockholm, 2009/3/20.

  9. Yoshida S. Kawakami S, Numao N, Ishii C, Tanaka H, Saito K, Koga F, Masuda H, Fujii Y, Kihara K. Multi-sequence magnetic resonance imaging prior to prostate biopsy:Correlation analysis using the pathological results of three-dimensional 26-core biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

  10. Numao N. Kawakami S, Fujii Y, Masuda H, Koga F, Sakai Y, Yonese J, Ishikawa Y, Fukui I, Kihara K. Characterization of prostate cancers missed by transrectal 12-core biopsy. “Best Poster Presentation”. EAU Annual Congress, Stockholm, 2009/3/20.

米国臨床癌学会泌尿生殖器癌シンポジウム(American Society of Clinical Oncology, Genitourinary Cancers Symposium)
  1. Tatokoro M, Fujii Y, Matsuoka Y, Komai F, Koga F, Saito K, Masuda H, Kawakami S, Kihara K. Phase II trial combination treatment of interferon-alfa, cimetidine, cyclooxygenase-2 inhibitor, and rennin-angiotensin system inhibitor in advanced renal cell carcinoma. American Society of Clinical Oncology, 2009 Genitourinary Cancers Symposium, USA, 2009/2/28.

2008年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Fujii Y, Komai K, Yonese J, Kawakami S, Saito K, Iimura Y, Kihara K, Fukui I. Incidence of benign pathologic lesions at partial nephrectomy for renal masses presumed to be renal cell carcinoma: Japanese dual-center experience with 176 consecutive patients. 103th annual meeting of AUA (AUA 2008), Orlando, USA, May 19, 2008.

  2. Saito K, Kawakami S, Fujii Y, Sakura M, Koga F, Masuda H, Kobayashi T, Kihara K Lymphovascular Invasion is Independently Associated with Poor Prognosis in Patients with Localized Upper Urinary Tract Urothelial Carcinoma Treated Surgically 103th annual meeting of AUA (AUA 2008), Orlando, USA, 2008/05/19

  3. Saito K, Tatokoro M, Iimura Y, Fujii Y, Sakai Y, Koga F, Kobayashi T, Kawakami S, Kihara K Prognostic impact of C-reactive protein response in patients with metastatic renal cell carcinoma 103th annual meeting of AUA (AUA 2008), Orlando, USA, 2008/05/18

  4. Iimura Y, Saito K, Tatokoro M, Fujii Y, Sakai Y, Koga F, Kobayashi T, Kawakami S, Kihara K. Preoperative C-reactive protein is a significant factor of prediction model for cancer specific survival in patients with clear cell renal cell carcinoma. 103th annual meeting of AUA (AUA 2008), Orlando, USA, May20, 2008.

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Kobayashi T, Sakura M, Kawakami S, Yoshida S, Tatokoro M, Yokoyama M, Sakai Y, Koga F, Saito K, Fujii Y, Kihara K. Prospective comparative study of single intravenous versus single oral administration of antimicrobial prophylaxis in minimum incision endoscopic radical prostatectomy. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

  2. Koga F, Kawakami S, Yoshida S, Saito K, Fujii Y, Kihara K. Favorable outcomes of T3N0M0 bladder cancer patients treated with induction low-dose chemoradiotherapy plus partial or radical cystectomy compared to immediate radical cystectomy. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

  3. Numao N, S. Kawakami, M. Sakura, J. Yonese, I. Fukui , Y. Ishikawa, K. Kihara. Which Gleason score should be applied, global or highest Glesaon score ? Grade concordance between extended biopsy and prostatectomy according to modified Gleason grading system. 23rd annual EAU congress, Milan, March 28, 2008.

  4. Saito K, Yoshida S, Yokoyama M, Sakura M, Sakai Y, Koga F, Masuda H, Fujii Y, Kobayashi T, Kawakami S, Kihara K. Absence of prophylactic antibiotics in minimum incision endoscopic surgery (MIES) of adrenal and renal tumour. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

  5. Yoshida S, Masuda H, Ishii C, Numao N, Sakai Y, Saito K, Koga F, Fujii Y, Kobayashi T, Kawakami S, Kihara K. Functional imaging of upper urinary tract neoplasm by diffusion-weighted MRI. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

米国臨床癌学会泌尿生殖器癌シンポジウム(American Society of Clinical Oncology, Genitourinary Cancers Symposium)
  1. Kawakami S, Numao N, Yamamoto S, Yonese J, Fujii Y, Yokoyama M, Sakura M, Komai Y, Fukui I, Kihara K. Extended biopsy-based nomograms predicting prostate cancer on initial biopsy in men with PSA < 20 mg/mL. 2008 Genitourinary Cancers Symposium. San Francisco, USA, Feb 14, 2008.

2007年

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Masuda H, Chancellor MB, Kihara K, de Groat WC, Yoshimura N. Inhibitory effects of 15d-PGJ2 on the detrusor overactivity caused by cyclophosphamide-induced cystitis. AUA annual meeting, Anaheim, May 21, 2007

  2. Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y, Kihara K. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. AUA 2007 annual meeting, Anaheim, May 20, 2007

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Matsuoka Y, Masuda H, Yokoyama M, Kihara K. Heme. Oxygenase-1 Attenuates Cyclophosphamide-induced Cystitis in Rats. 22th Annual EAU Congress. Berlin, Mar 22, 2007

  2. Numao N, Kawakami S, Yokoyama M, Yonese J, Ishikawa Y, Nakanishi Y, Arisawa C, Ando M, Fukui I, Kihara K. A prostate biopsy scheme optimal for both cancer detectability and grade accuracy. 22st Annual EAU congress, Berlin, Mar 22, 2007

国際泌尿器科学会(Congress of the societe Internationale d'Urologie)
  1. Fujii Y, Yamamoto S, Yonese J, Kawakami S, Okubo Y, Suyama T, Komai Y, Kijima T, Fukui I. Simple and east technique to prevent post-radical retropubic prostatectomy inguinal hernia, 29th congress of the societe internationale d’urologie. Paris, Sep 5, 2007

  2. Fujii Y, Yonese J, Kawakami S, Yamamoto S, Okubo Y, Suyama T, Komai Y, Kijima T, Fukui I. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer. 29th congress of the societe internationale d’urologie, Paris, Sep 5, 2007

  3. Koga F, Yoshida S, Kageyama Y, Kawakami S, Fujii Y, Saito K, Masuda H, Kobayashi T, Kihara K. Induction low-dose chemoradiotherapy against muscle-invasive bladder cancer: Posssible improvement of survival and favorable local control for bladder preserved patients. SIU 29th Congress of the societe Internationale d'Urologie, Paris, Sep 4, 2007

  4. Yoshida S, Masuda H, Ishii C, Matsuoka Y, Saito K, Kawakami S, Kihara K. Initial Experience of Functional Imaging of Upper Urinary Tract Urotherial Carcinoma By Diffusion-weighted. MRI SIU 2007 annual meeting, Paris, Sep 4, 2007

  5. Yoshida S, Saito K, Koga F, Kageyama Y, Yokoyama M, Matsuoka Y, Masuda H, Kobayashi T, Kawakami S, Kihara K. C-reactive Protein Predicts Prognosis of Muscle-invasive Bladder Cancer Patients Treated With Chemoradiotherapy. SIU 2007 annual meeting. Paris, Sep 4, 2007